Status:

UNKNOWN

Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal Dysfunction

Lead Sponsor:

Gachon University Gil Medical Center

Collaborating Sponsors:

Gangnam Severance Hospital

Severance Hospital

Conditions:

Contrast-induced Nephropathy

Eligibility:

All Genders

19+ years

Phase:

PHASE4

Brief Summary

Contrast-induced nephropathy (CIN) is a well-recognized complication of radiographic contrast administration and is associated with increased short- and long-term mortality. Previous strategies includ...

Eligibility Criteria

Inclusion

  • Age ≥ 19 years
  • Need for coronary angiography or intervention in patients with typical symptoms for angina or myocardial infarction, or documented myocardial ischemia at non-invasive studies including ECG, treadmill ECG test, heart spect or coronary CT angiography
  • Estimated glomerular filtration rate ≤60 mL/min
  • Informed consent

Exclusion

  • Need for primary percutaneous coronary intervention or emergent intervention in patients with myocardial infarction
  • Allergic reaction for contrast agent (Visipaque) or statin
  • Contraindication for contrast agent (Visipaque) or statin
  • Shock status fron any cause including cardiogenic shock
  • Statin use before enrollment (Enrollment after 2 weeks of wash-out period)
  • Exposure of contrast agent within 7 days before enrollment
  • Pregnancy or Expectation for pregnancy in women of childbearing age
  • Heart failure (NYHA class ≥3 or left ventricular ejection fraction \< 40%)
  • Acute renal injury
  • Dialysis therapy
  • Mechanical ventilator
  • Life expectancy \< 6 months
  • Non-steroidal anti-inflammatory drug, dopamine, mannitol or N-acetylcysteine, ascorbic acid within 48 hours before and after coronary angiography/intervention
  • Severe hepatic dysfunction
  • Eisenmenger syndrome or idiopathic pulmonary hypertension
  • Renal artery angioplasty within 6 months
  • Single functioning kidney
  • Kidney transplantation

Key Trial Info

Start Date :

June 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2014

Estimated Enrollment :

404 Patients enrolled

Trial Details

Trial ID

NCT01871792

Start Date

June 1 2013

End Date

February 1 2014

Last Update

June 7 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Gachon University Gil Hospital

Incheon, South Korea, 405-760